Clinical Professor of Medicine, UCLA
Cardiology
Dr. Jon A. Kobashigawa, MD
|
|
Give Review
Dr. Jon A. Kobashigawa works in the field of Cardiology. He studied medicine at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai has a rank of 20 in research and a 62 in primary care He over the years received 13 awards: "Fellow (FAHA)", "Fellow (FACC)", "Co-Chair, Thoracic Community of Practice Committee", "Past President", "Past Chair", "Past Member", "Executive Program Committee", "America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:Southern California", "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Jon A. Kobashigawa, MD has written publications. He has 93 publications published with PubMed. The lastest paper is: 'Total Artificial Heart as Bridge to Heart Transplantation in Chagas Cardiomyopathy: Case Report.' Jon A. Kobashigawa, MD is registered with Medicare and accepts Medicare payments.
Publications
- Desensitization Strategies Pre- and Post-Cardiac Transplantation.
- Echocardiographic parameters associated with right ventricular Failure after left ventricular assist device: A review.
- Slowing Sinus Tachycardia in Heart Transplant Recipients: Is It Time?
- The Changing Face of First-Year Intravascular Ultrasonography in Heart Transplantation.
- Prior sternotomy increases the mortality and morbidity of adult Heart transplantation.
- Adult cardiothoracic transplant nursing: an ISHLT consensus document on the current adult nursing practice in Heart and lung transplantation.
- Elevated immune monitoring early after cardiac transplantation is associated with increased plaque progression by intravascular ultrasound.
- Extracorporeal photopheresis in Heart transplant rejection.
- Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and Heart transplant candidacy.
- Anti-thymocyte gamma-globulin may prevent antibody production after Heart transplantation.
- Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in Heart allografts.
- Long-term care of the Heart transplant recipient.
- U.S. Donor Heart Allocation Bias for Men Over Women?: A Closer Look.
- Chagas Disease in solid organ and heart transplantation.
- Long-term outcomes of orthotopic heart transplantation for hypertrophic Cardiomyopathy.
- Selecting oversized donor cardiac allografts for patients with Pulmonary hypertension may be unnecessary.
- The Policy of Placing Older Donors into Older Recipients: Is it Worth the Risk?
- Time for change in United States donor Heart allocation policy.
- Coronary Computed Tomography Angiography: Is it time to replace the conventional Coronary angiogram in heart transplant patients?
- Management of the ACC/AHA Stage D Patient: Cardiac Transplantation.
- Atypical hemolytic-uremic Syndrome immediately after heart transplantation.
- Immunosuppression following Heart transplantation: prospects and challenges.
- Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: Impact of tacrolimus versus cyclosporine.
- Correlation between Myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation.
- Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients: Substudy From the Everolimus Versus Mycophenolate Mofetil Randomized, Multicen...
- Increased Negative Impact of Donor HLA-Specific Together With Non-HLA-Specific Antibodies on Graft Outcome.
- Clinical and Angiographic Outcomes with Everolimus Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy.
- The impact of mean first-year Heart rate on outcomes after Heart transplantation: does it make a difference?
- Frequency of Coronary artery fistulae is increased after orthotopic heart transplantation.
- Everolimus versus mycophenolate mofetil in Heart transplantation: a randomized, multicenter trial.
- Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.
- The future of Heart transplantation.
- Antibody-mediated rejection.
- The use of the calculated panel-reactive antibody and virtual crossmatch in Heart transplantation.
- Management of Heart transplant recipients: reference for primary care physicians.
- Improving survival during Heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.
- Heart transplantation.
- Heart transplant recipients supported with extracorporeal membrane oxygenation: Outcomes from a single-center experience.
- HLA and MICA: Targets of Antibody-Mediated Rejection in Heart Transplantation.
- Everolimus for Cardiac Allograft Vasculopathy-Every Patient, at any Time?
- Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience.
- Prolonged QT and cardiac arrest after Heart transplantation: inherited or acquired?
- Management of advanced Heart failure: the role of Heart transplantation.
- Homeless donors and Heart transplantation outcomes.
- Strategies in immunosuppression after Heart transplantation: is less better?
- Retrospective review of Japanese patients undergoing Heart transplantation in Japan compared with those undergoing transplantation in the United States.
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.
- Benefit of immune monitoring in Heart transplant patients using ATP production in activated lymphocytes.
- Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardia...
- Tricuspid Valve regurgitation after heart transplantation.
- Asymptomatic antibody-mediated rejection after Heart transplantation predicts poor outcomes.
- Mode and mechanisms of death after orthotopic Heart transplantation.
- Use of Hearts transplanted from donors with severe sepsis and infectious deaths.
- Use of bortezomib as adjunctive therapy for densensitization in combined Heart and kidney transplantation--a case report.
- Supraventricular tachycardia after orthotopic cardiac transplantation.
- Symptomatic osteonecrosis of the hip and knee after cardiac transplantation.
- A lower incidence of cytomegalovirus infection in de novo Heart transplant recipients randomized to everolimus.
- Vascular remodeling 1 year after cardiac transplantation.
- Contemporary concepts in noncellular rejection.
- Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.
- Cardiac allograft vasculopathy in Heart transplant patients: pathologic and clinical aspects for angioplasty/stenting.
- Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in Heart transplant recipients.
- Usefulness and safety of percutaneous Coronary interventions for cardiac transplant vasculopathy.
- Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in Heart transplant patients.
- Should we be doing routine biopsy after Heart transplantation in a new era of anti-rejection?
- The revised ISHLT Heart biopsy grading scale.
- Ten-year follow-up of a randomized trial of pravastatin in Heart transplant patients.
- Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.
- Multicenter intravascular ultrasound validation study among Heart transplant recipients: outcomes after five years.
- The University of California at Los Angeles Heart transplantation experience.
- Statins and cardiac allograft vasculopathy after Heart transplantation.
- "International camaraderie"--excerpts from the ISHLT 2004 Presidential Address.
- Advances in Heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-...
- Sudden, unexpected death in cardiac transplant recipients: an autopsy study.
- Cardiac transplantation: the alternate list and expansion of the donor pool.
- The prevalence of calcified carotid atheromas on the panoramic radiographs of patients with dilated Cardiomyopathy.
- Immunosuppression, diagnosis, and treatment of cardiac allograft rejection.
- IntraCoronary radiation to treat in-stent restenosis in six cardiac transplant patients.
- Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study.
- First-year intravascular ultrasound results as a surrogate marker for outcomes after Heart transplantation.
- FK506 vs. cyclosporin. Pathologic findings in 1067 endoMyocardial biopsies.
- Seventeen-year experience with 1,083 Heart transplants at a single institution.
- Cutting Balloon angioplasty for cardiac transplant vasculopathy.
- Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy.
- Heart transplantation for end-stage Heart failure due to cardiac sarcoidosis.
- Failing the failing Heart: a review of palliative care in Heart failure.
- Combined Heart-kidney transplantation after total artificial Heart insertion.
- Heart Transplantation With and Without Prior Sternotomy: Analysis of the United Network for Organ Sharing Database.
- Total Artificial Heart as Bridge to Heart Transplantation in Chagas Cardiomyopathy: Case Report.
- The natural history of biopsy-negative rejection after Heart transplantation.
- Adult Heart Transplantation Following Ventricular Assist Device Implantation: Early and Late Outcomes.
- Leading Efforts to Increase Organ Donation Through Professionalization of Organ Procurement Organizations and Establishment of Organ and Tissue Donor Registries.
Schools
Mount Sinai School Of Medicine Of New York University
UCLA Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FAHA)
- Fellow (FACC)
- Co-Chair, Thoracic Community of Practice Committee
- Past President
- Past Chair
- Past Member
- Executive Program Committee
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:Southern California
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Super Doctor
Education
-
UCLA Medical Center -
Icahn School of Medicine at Mount Sinai -
Stanford University
Hospital
-
Ronald Reagan UCLA Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1467548073 | |
| NPPES Provider LastName | KOBASHIGAWA | |
| NPPES Provider FirstName | JON | |
| NPPES Provider ZIPCode | 900956988 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 4712.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 0.25 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467548073 |
| Last Name Of The Provider | KOBASHIGAWA |
| First Name Of The Provider | JON |
| View All |
Similar Doctors
|
|
Dr. Amita R. Dharawat, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Helfenstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Conwell Newton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ilan Kedan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Debra R. Judelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hooman Madyoon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reed S. Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj M. Khandwalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antoine Alhajje, MD |
|
|
Dr. Joshua Penn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mazen M. Sawaf, MD |